[1] GBD 2021 Rheumatoid Arthritis Collaborators. Global, regional, and national burden of rheumatoid arthritis, 1990-2020, and projections to 2050: A systematic analysis of the Global Burden of Disease Study 2021BD 2021 Rheumatoid Arthritis Collaborators. Global, regional, and national burden of rheumatoid arthritis, 1990-2020, and projections to 2050: A systematic analysis of the Global Burden of Disease Study 2021[J]. Lancet Rheumatol, 2023, 5(10): e594-e610. [2] Wei L, Chen X, Liu M.Global, regional, and national burden and trends of rheumatoid arthritis among the elderly population: An analysis based on the 2021 Global Burden of Disease study[J]. Front Immunol, 2025, 16: 1547763. [3] 海峡两岸医药卫生交流协会风湿免疫病学专业委员会慢病管理学组. 类风湿关节炎慢病管理专家指导建议[J]. 中华内科杂志, 2023, 62(11): 1256-1265. [4] Tian X, Wang Q, Jiang N, et al.Chinese guidelines for the diagnosis and treatment of rheumatoid arthritis: 2024 update[J]. Rheumatol Immunol Res, 2025, 5(4): 189-208. [5] Cutolo M, Smith V, Paolino S, et al.Involvement of the secosteroid vitamin D in autoimmune rheumatic diseases and COVID-19[J]. Nat Rev Rheumatol, 2023, 19(5): 265-287. [6] 中国营养学会健康管理分会. 维生素D营养状况评价及改善专家共识[J]. 中华健康管理学杂志, 2023, 17(4): 245-252. [7] Messina OD, Clark P, Torres JM, et al.Vitamin D in inflammatory rheumatic diseases: Still a challenge[J]. Osteoporos Int, 2026, 37(5): 1221-1231. [8] Zha X, Liu Y, Jiang Y, et al.Correlations between serum vitamin D, synovial succinic acid levels and disease activity in patients with rheumatoid arthritis[J]. J Inflamm Res, 2026, 19: 1-11. [9] Rodziewicz A, Bryl E.The role of microbiome and diet on disease activity and immune-inflammatory status in rheumatoid arthritis[J]. Nutrients, 2026, 18(9): 1325. [10] 耿研, 谢希, 王昱, 等. 类风湿关节炎诊疗规范[J]. 中华内科杂志, 2022, 61(1): 51-59. [11] Aletaha D, Neogi T, Silman AJ, et al.2010 Rheumatoid arthritis classification criteria: An American College of Rheumatology/European League Against Rheumatism collaborative initiative[J]. Arthritis Rheum, 2010, 62(9): 2569-2581. [12] 姜冰, 李兴华, 呼靖宣, 等. 类风湿性关节炎患者25羟维生素D水平及其与疾病活动的相关性研究[J]. 西北国防医学杂志, 2021, 42(3): 195-198, F0003. [13] 张彪, 曾丽娥, 卢鑫鑫, 等. 常见自身免疫性疾病患者血清25-羟维生素D水平的差异分析[J]. 检验医学与临床, 2024, 21(7): 895-899. [14] 张楠, 时鹏, 年娣. 维生素D在自身免疫性疾病中的研究进展[J]. 检验医学与临床, 2021, 18(21): 3197-3200. [15] 柯丹, 闫蕊, 赵学刚, 等. 类风湿关节炎患者血清维生素D水平及其影响因素分析[J]. 中国食物与营养, 2022, 28(12): 83-85, 20. [16] 贾筠, 杜望磊, 肖广智, 等. 类风湿关节炎血清趋化因子RNAKL及25-羟维生素D水平与疾病进展的相关性分析[J]. 河北医学, 2022, 28(11): 1826-1831. [17] 孟静楠, 赵韵琦, 张伦军, 等. 类风湿关节炎患者外周血25羟基维生素D、白介素-6的表达[J]. 中国临床研究, 2022, 35(2): 190-193. [18] Ranjbar M, Rahimlou M, Fallah M, et al.Effects of vitamin D supplementation in patients with rheumatoid arthritis: A systematic review and meta-analysis[J]. Heliyon, 2025, 11(3): e42463. [19] Izzo O, Gotelli E, Hysa E, et al.Effects of vitamin D on epigenetics, seasonality, and management of rheumatoid arthritis[J]. Nutrients, 2026, 18(14): 2359. [20] Hahn J, Cook NR, Alexander EK, et al.Vitamin D and marine omega 3 fatty acid supplementation and incident autoimmune disease: VITAL randomized controlled trial[J]. BMJ, 2022, 376: e066452. [21] Li P, Zhu X, Cao G, et al.1α,25(OH)D reverses exhaustion and enhances antitumor immunity of human cytotoxic T cells[J]. J Immunother Cancer, 2022, 10(3): e003477. [22] Rivera-Escoto M, Campos-López B, Pesqueda-Cendejas K, et al.Analysis of potential vitamin D molecule biomarkers: Association of calcitriol and its hydroxylation efficiency ratio with cardiovascular disease risk in rheumatoid arthritis patients[J]. Biomedicines, 2024, 12(2): 273. [23] Maisha JA, El-Gabalawy HS, O'Neil LJ. Modifiable risk factors linked to the development of rheumatoid arthritis: Evidence, immunological mechanisms and prevention[J]. Front Immunol, 2023, 14(1): 1221125. |